INVITE: Guggenheim Grand Rounds - The Good, The Bad, and The Ugly in Pulmonary Fibrosis Drug Development with Two Leading Experts

Research evidence excerpt

INVITE: Guggenheim Grand Rounds - The Good, The Bad, and The Ugly in Pulmonary Fibrosis Drug Development with Two Leading Experts

BIOTECHNOLOGY

June 9, 2026

DISCLAIMER

Important Notices and Disclosures Please forward the language below to your Compliance

team: Guggenheim Securities, LLC is providing notice to you and your firm’s Compliance

department that we have invited personnel from your firm to attend the above-referenced

event. Attendees are advised that any information or materials discussed at the event

or provided in connection therewith (the “materials”) are provided for informational and

educational purposes only and should not be considered a recommendation of any particular

security, strategy or investment product, as investing advice of any kind, or as offering or

providing any investment product or service, or as an offer or solicitation with respect to the

purchase or sale of any investment by Guggenheim Securities, LLC or any of its affiliates

(“Guggenheim”). The materials are not provided in an advisory or fiduciary capacity and

may not be relied upon for or in connection with the making of investment decisions. The

views expressed during the event and/or in the materials are solely those of the authors,

participants, investment bankers and other presenters (collectively, the “Presenters”) and

may differ from the views of other officers, directors, employees or other representatives

(as to any person or entity, its “Representatives”) of Guggenheim or any other Presenter.

The Presenters’ opinions are subject to change without notice. Neither Guggenheim nor any

other Presenter undertakes any obligation to provide additional information or any update to

or correction of the information discussed or provided at the event or otherwise in connection